Why the study?
What is the incidence, etiology, and optimal management of venous thromboembolism in patients with malignant brain tumors?
Population
Patients with primary or malignant brain tumors
Design
Review
Authors
Loading...
May support anticoagulation in malignant brain tumor patients with VTE; leaves open need for prospective trials.
What is the incidence, etiology, and optimal management of venous thromboembolism in patients with malignant brain tumors?
Patients with malignant brain tumors can be safely anticoagulated with carefully monitored heparin and warfarin, with a low risk of intracranial bleeding.
Steven J. Jubelirer (1996) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: